Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

Andreas Mackensen^#^{1

2}, Fabian Müller^#^{1

2}, Dimitrios Mougiakakos^#^{1

2

3}, Sebastian Böltz^{2

4}, Artur Wilhelm^{2

4}, Michael Aigner^{1

2}, Simon Völkl^{1

2}, David Simon^{2

4}, Arnd Kleyer^{2

4}, Luis Munoz^{2

4}, Sascha Kretschmann^{1

2}, Soraya Kharboutli^{1

2}, Regina Gary^{1

2}, Hannah Reimann^{1

2}, Wolf Rösler^{1

2}, Stefan Uderhardt^{2

4}, Holger Bang⁵, Martin Herrmann^{2

4}, Arif Bülent Ekici⁶, Christian Buettner⁶, Katharina Marie Habenicht⁷, Thomas H Winkler⁷, Gerhard Krönke^#^{2

4}, Georg Schett^#^{8

9}

Affiliations

¹ Department of Internal Medicine 5-Hematology and Oncology, Friedrich Alexander University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
² Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
³ Department of Hematology and Oncology, Otto-von-Guericke University Magdeburg (OVGU), Magdeburg, Germany.
⁴ Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
⁵ Orgentec, Mainz, Germany.
⁶ Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
⁷ Division of Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
⁸ Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany. georg.schett@uk-erlangen.de.
⁹ Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany. georg.schett@uk-erlangen.de.

^# Contributed equally.

Published Erratum

Andreas Mackensen et al. Nat Med. 2023 Nov.

. 2023 Nov;29(11):2956.

doi: 10.1038/s41591-022-02091-9.

¹ Department of Internal Medicine 5-Hematology and Oncology, Friedrich Alexander University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
² Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
³ Department of Hematology and Oncology, Otto-von-Guericke University Magdeburg (OVGU), Magdeburg, Germany.
⁴ Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
⁵ Orgentec, Mainz, Germany.
⁶ Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
⁷ Division of Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
⁸ Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany. georg.schett@uk-erlangen.de.
⁹ Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany. georg.schett@uk-erlangen.de.

^# Contributed equally.

No abstract available

Erratum for

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.
Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, Simon D, Kleyer A, Munoz L, Kretschmann S, Kharboutli S, Gary R, Reimann H, Rösler W, Uderhardt S, Bang H, Herrmann M, Ekici AB, Buettner C, Habenicht KM, Winkler TH, Krönke G, Schett G. Mackensen A, et al. Nat Med. 2022 Oct;28(10):2124-2132. doi: 10.1038/s41591-022-02017-5. Epub 2022 Sep 15. Nat Med. 2022. PMID: 36109639